Alzheimer’s research may see a well needed boost in the form of a research deal funded by Chicago based pharmaceutical group AbbVie. The recipient research group, Alector, is to receive a $205 million USD up front payment, as well as future equity investments worth up to $20 million. Alector has seen a great deal of interest within the … [Read more...] about Immunotherapy: the future of Alzheimer’s research?
Hyderus Cyf and Hyderus Teoranta
Videos
The Three Commitments
Why Consultants end up not telling the truth
The worst kind of market research interviewing technique ever
Why bright people can’t explain themselves
Clients
